Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check out post #26!!
$OTIC
Thanks the beauty of this carnage for those who didn't previously hold a position. I believe there are also 4 pipeline drugs as well.
Sorry meant cash $150 mil
No worry here though
OS 30 mil, cash 4150 mil . . .this should reach $5.
I only worry if the company have no more catalysts, this one has more Phase results forth coming and a NDA in 1stQ 2018 :) Trading well below cash = no brain buy imo.
Pop $4.00 breaks on to next targets. Now $4.10 it pays to know what you trade. DD is a must. After $4.10 we break $4.30 then should run back to the high $4s $5s happy trading.
Not break out yet
Real traders know this is ready to break, Pop over that $4.00 and we should run nice. Still well below cash levels here @ $3.95
long here for a massive rebound!
$3.90 thank God you have your good looks
Agreed. I'm still trying to learn patience but I'm getting better haha
Being little patient is a quality in trading :)
Above $4.00 could see a big push up
Book and cash just below $5, no reason this shouldn't bounce hard
Same. Will get back in if it breaks 4
I'm out at $3.75, no bounce, I'm out
Sadly...buyers from yesterday bought at a 52-week high.
Volume suggesting YUGE interest at current PPS.
Could be a good play here, not a one trick pony they have a good pipe line and are set to file NDA in 2018.
Phase 3 trial met primary endpoint - January 5, 2017. PDUFA date for sNDA filing March 2, 2018.
http://investors.otonomy.com/phoenix.zhtml?c=234082&p=irol-newsArticle_Print&ID=2286970
Market Cap $105 Million / Cash $150 MILLION / 1 Drug approved / Another one under review by FDA , approval likely in March = STRONG BUY AGGRESSIVEEEEEE $10 easily
sNDA Filing Accepted and PDUFA Action Date Assigned for OTIPRIO® in Acute Otitis Externa (AOE): In July, Otonomy announced that its Supplemental New Drug Application (sNDA) for the approval of OTIPRIO (ciprofloxacin otic suspension) as a treatment for patients with AOE was accepted for filing by the U.S. Food and Drug Administration (FDA) and assigned a Prescription Drug User Fee Act (PDUFA) action date of March 2, 2018. The acceptance of the sNDA indicates that the application is sufficiently complete to permit a substantive review by the FDA.
Well. I'm already up significantly, I'll sell at the pop at open and buy a dip once confirmed.
$5 close..
I have buy limits all the way to $5
Today.
$5 close ideal.
Small starter at 3.45
Scared money don't make money
Go for it . .. as long as you have an exit strategy . . . Historical low is $10. so anything goes . . . They have cash of $150 mil, don't know Float . .. it might give and idea of bottom SP.
THESE PRICES REFLECT AN ALL TIME RECORD LOW
MIGHT BE A NICE BOUNCER
ANY HOPE?
ANY OTHER PRODUCTS IN THE PIPELINE?
OR EVERYTHING WAS RIDING ON THIS?
Dice roll...gonna try for some at $3.58.
Definitely . . .It is now getting below $4.
Followers
|
27
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
549
|
Created
|
12/27/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |